Answered on the record on 30 October 2026, from the files as they stood that day Trending
Kiniksa Pharmaceuticals and Supernus Pharmaceuticals are the busiest drugmakers in the record, with 3 filing events each in the fourteen days to 29 October 2026, of the 96 events the family's report lists. Eight more made 2 each, and every other drugmaker with an event made one.
How this list was made. The family report for Pharmaceutical Preparations, industry code 2834, lists the newsworthy filings its 497 members made from 15 October to 29 October 2026, one event per filing. An event is a quarterly or annual report, a late-report notice, or a current report on news such as results, a major agreement or an officer or director change. Insider forms and stories are not counted; the events are counted per company, and every drugmaker with more than one is listed, the most first, then by ticker.
- KNSAKiniksa Pharmaceuticals International, plc 3 filing eventsIts 3 filings: on 22 October 2026, a current report on an officer or director change; on 27 October 2026, a current report releasing results and a quarterly report.
- SUPNSupernus Pharmaceuticals, Inc. 3 filing eventsIts 3 filings, all current reports: on 15 October 2026, the results of a shareholder vote; on 19 October 2026, results released; on 26 October 2026, a major agreement ended.
- ACRSAclaris Therapeutics, Inc. 2 filing eventsIts 2 filings, both current reports on 27 October 2026: one releasing results and one on a major agreement signed.
- AMRNAmarin Corporation plc 2 filing eventsIts 2 filings, both on 28 October 2026: a current report releasing results and a quarterly report.
- BHCBausch Health Companies Inc 2 filing eventsIts 2 filings: on 28 October 2026, a current report releasing results; on 29 October 2026, a quarterly report.
- GOVXGeoVax Labs, Inc. 2 filing eventsIts 2 filings, both current reports on 27 October 2026: the results of a shareholder vote and a major agreement signed.
- TPSTTempest Therapeutics, Inc. 2 filing eventsIts 2 filings, both current reports: on 19 October 2026, an officer or director change; on 20 October 2026, the results of a shareholder vote.
- TRAXFirst Tracks Biotherapeutics, Inc. 2 filing eventsIts 2 filings are current reports on major agreements signed, on 15 October 2026 and on 20 October 2026.
- VKTXViking Therapeutics, Inc. 2 filing eventsIts 2 filings: on 28 October 2026, a current report releasing results; on 29 October 2026, a quarterly report.
- WVEWave Life Sciences Ltd. 2 filing eventsIts 2 filings, both on 27 October 2026: a current report releasing results and a quarterly report.
Across the family
Of the family's 96 events, 32 were officer or director changes, 20 major agreements signed, 16 results releases and 8 quarterly reports. The rest were shareholder votes, notices about an exchange listing, annual reports and a few other current reports.
By the desk, an AI model, from the record alone (ruling 162). Every figure is a field of the files named above, matched by value when the answer was staged. Nothing here is advice, and nothing here is a price.
Ask your own question → Every answer